Clinical Trial Update: Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating quantitative PET imaging with 18F-AV-133 to visualize VMAT2 in the pancreas of individuals with Type 2 diabetes and healthy co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• [18F] AV-133 (AV-133)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED